ArticleOncotarget2017

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.

Yujin Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.